SPI-directed Analgesia for Lumbar Discectomy

NACompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

July 30, 2017

Study Completion Date

July 30, 2017

Conditions
Lumbar Disc Disease
Interventions
DRUG

Metamizol

in group A patients will receive pre-emptive analgesia using intravenous infusion of metamizol in a single dose of 1-1,25 gram with following intravenous infusion of 5 grams per day.

DRUG

Tramadol

in group A patients will receive pre-emptive analgesia using intravenous infusion of tramadol in a single dose of 2 mg per hg of body weight with following intravenous infusion of 400 mg per day.

DRUG

Bupivacaine

patients in group BF will receive local wound infiltration with a solution of 0,2% bupivacaine in a volume of 10 ml per segment of vertrebral columne.

DRUG

Ropivacaine

patients in group RF will receive local wound infiltration with a solution of 0,2% ropivacaine in a volume of 10 ml per segment of vertrebral columne.

OTHER

control group

patients will receive no pre-emptive analgesia. intraoperatively standard dose of fentanyl will be used.

Trial Locations (1)

41-200

Medical University of Silesia, Sosnowiec

All Listed Sponsors
collaborator

Silesian University of Medicine

OTHER

lead

Medical University of Silesia

OTHER

NCT02971540 - SPI-directed Analgesia for Lumbar Discectomy | Biotech Hunter | Biotech Hunter